Veracyte, Inc. (VCYT)
42.30
+0.20
(+0.48%)
USD |
NASDAQ |
Jan 02, 10:20
Veracyte Cash from Investing (Quarterly): 48.26M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | -4.123B |
| FONAR Corp. | -2.367M |
| XWELL, Inc. | 1.715M |
| ProPhase Labs, Inc. | 0.00 |
| Insight Molecular Diagnostics, Inc. | -1.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 44.76M |
| Cash from Financing (Quarterly) | 2.977M |
| Free Cash Flow | 98.21M |
| Free Cash Flow Per Share (Quarterly) | 0.5266 |
| Free Cash Flow to Equity (Quarterly) | 52.16M |
| Free Cash Flow to Firm (Quarterly) | 41.96M |
| Free Cash Flow Yield | 2.92% |